Marion Odence-Ford - 19 Dec 2024 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Role
General Counsel and CCO
Signature
/s/ Marion K. Odence-Ford
Issuer symbol
OPRX
Transactions as of
19 Dec 2024
Transactions value $
-$5,477
Form type
4
Filing time
20 Dec 2024, 19:48:14 UTC
Previous filing
12 Nov 2024
Next filing
27 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPRX Common Stock Options Exercise $0 +3.93K +16.06% $0.00 28.4K 19 Dec 2024 Direct F1
transaction OPRX Common Stock Tax liability -$5.48K -1.15K -4.06% $4.75 27.2K 20 Dec 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPRX Restricted Stock Units Options Exercise $0 -3.93K -33.33% $0.00 7.86K 19 Dec 2024 Common Stock 3.93K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
F3 The restricted stock units vest in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.